OBJECTIVES: We sought to identify metabolic pathways characterizing human heart failure (HF) using ¹NMR based urinary metabolomic analysis in conjunction with multivariate statistics. DESIGN AND METHODS: Patients with systolic HF of ischemic origin (n=15) and healthy controls (n=20) participated in this study. Patients with type 2 diabetes mellitus were excluded. RESULTS: The results showed that the urine of the HF patients had higher levels of metabolites for acetate (p<0.05) and acetone (p<0.01) compared to the healthy controls. In addition, there was a perturbation in methylmalonate metabolism as shown by increased urinary levels of methylmalonic acid (p<0.001) in the HF patients. HF patients also had increased urinary levels of cytosi...
There is intense interest in the identification of novel biomarkers which improve the diagnosis of h...
Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the...
BACKGROUND: Metabolic impairment is an important contributor to heart failure (HF) pathogenesis and ...
Heart failure (HF) is characterized by a series of maladaptive metabolic changes, which have recentl...
Objective: Elevated myocardial energy expenditure (MEE) is related with reduced left ventricular eje...
OBJECTIVE: Elevated myocardial energy expenditure (MEE) is related with reduced left ventricular eje...
Heart failure (HF) is characterized by a series of adaptive changes in energy metabolism. The use of...
Background: Measurement of small molecules of intermediary metabolism (‘metabolites’) is an emerging...
The metabolic changes that accompany changes in Cardiopulmonary testing (CPET) and heart failure bio...
OBJECTIVES: To test the hypothesis that urinary metabolites characterizing heart failure (HF) are as...
Contains fulltext : 218291.pdf (Publisher’s version ) (Open Access)BACKGROUND: Met...
In this study, urinary metabolic profiles of patients with heart failure (HF) and healthy individual...
There is intense interest in the identification of novel biomarkers which improve the diagnosis of h...
Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the...
BACKGROUND: Metabolic impairment is an important contributor to heart failure (HF) pathogenesis and ...
Heart failure (HF) is characterized by a series of maladaptive metabolic changes, which have recentl...
Objective: Elevated myocardial energy expenditure (MEE) is related with reduced left ventricular eje...
OBJECTIVE: Elevated myocardial energy expenditure (MEE) is related with reduced left ventricular eje...
Heart failure (HF) is characterized by a series of adaptive changes in energy metabolism. The use of...
Background: Measurement of small molecules of intermediary metabolism (‘metabolites’) is an emerging...
The metabolic changes that accompany changes in Cardiopulmonary testing (CPET) and heart failure bio...
OBJECTIVES: To test the hypothesis that urinary metabolites characterizing heart failure (HF) are as...
Contains fulltext : 218291.pdf (Publisher’s version ) (Open Access)BACKGROUND: Met...
In this study, urinary metabolic profiles of patients with heart failure (HF) and healthy individual...
There is intense interest in the identification of novel biomarkers which improve the diagnosis of h...
Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the...
BACKGROUND: Metabolic impairment is an important contributor to heart failure (HF) pathogenesis and ...